Beyond Air Signs Distribution Deals For LungFit PH

Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the recent signing of several key international distribution agreements for LungFit® PH, expanding its network to include Germany, Brazil, Austria, the Netherlands and Sri Lanka. These agreements bring the total international coverage to 39 countries, representing a combined population of more than three billion people.